Progress of adipose-derived stem cells in the treatment of lymphedema
10.3760/cma.j.cn114453-20210503-00196
- VernacularTitle:脂肪来源干细胞治疗淋巴水肿的研究进展
- Author:
Miaomiao WEI
1
;
Chengliang DENG
Author Information
1. 遵义医科大学附属医院烧伤整形外科，遵义 563000
- Keywords:
Lymphedema;
Adipose-derived stem cells;
Lymphangiogenesis;
Regenerative medicine
- From:
Chinese Journal of Plastic Surgery
2022;38(7):846-850
- CountryChina
- Language:Chinese
-
Abstract:
Currently, the incidence of lymphedema is increasing, which poses a serious threat to patients’ quality of life. Adipose-derived stem cells(ADSCs) have the potential of multi-directional differentiation, secretion of a variety of cytokines, and immune regulation ability, which made it one of the ideal stem cells in the field of regenerative medicine. This article intends to review the mechanism, animal studies and clinical trials of ADSCs in the treatment of lymphedema, in order to provide a systematic theoretical basis for ADSCs regeneration therapy of lymphedema.
